Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,614
Views
9
CrossRef citations to date
0
Altmetric
Letter

Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection

Dorothea Orth-Höllera MB-LAB – Clinical Microbiology Laboratory, Innsbruck, AustriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2904-5192
ORCID Icon,
Angelika Eigentlera MB-LAB – Clinical Microbiology Laboratory, Innsbruck, Austria
,
Lukas Weseslindtnerb Center of Virology, Medical University of Vienna, Vienna, Austria
&
Johannes Mösta MB-LAB – Clinical Microbiology Laboratory, Innsbruck, Austria
Pages 1692-1694 | Received 07 May 2020, Accepted 03 Jul 2020, Published online: 20 Jul 2020

References

  • Eurosurveillance Editorial T. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.200131e
  • Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045
  • Okba NMA, Müller MA, Li W, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020;26(7). doi: 10.3201/eid2607.200841
  • Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa344
  • Perera RAPM, Mok CKP, Tsang OTY, et al. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020;25(16). doi: 10.2807/1560-7917.ES.2020.25.16.2000421
  • Qu J, Wu C, Li X, et al. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa489
  • Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel Coronavirus disease (COVID-19). Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa310
  • Yongchen Z, Shen H, Wang X, et al. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):833–836. doi: 10.1080/22221751.2020.1756699
  • Sun B, Feng Y, Mo X. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;1:1–36. doi:10.1080/22221751.2020.1762515 doi: 10.1038/emi.2012.22
  • Traugott M, Aberle SW, Aberle JH, et al. Performance of SARS-CoV-2 antibody assays in different stages of the infection: comparison of commercial ELISA and rapid tests. J Infect Dis. 2020: jiaa305. doi: 10.1093/infdis/jiaa305

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.